A Phase II Study Comparing Salvage Radiotherapy in Combination With 6 Months of Androgen-deprivation Therapy Versus Anti-androgen Therapy With Apalutamide in Patients With Biochemical Progression After Radical Prostatectomy
Latest Information Update: 01 Jul 2024
At a glance
- Drugs Apalutamide (Primary) ; Degarelix; Goserelin; Leuprorelin; Triptorelin
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms SAVE
Most Recent Events
- 06 Feb 2024 Planned End Date changed from 1 Sep 2022 to 1 Dec 2025.
- 06 Feb 2024 Planned primary completion date changed from 1 Dec 2021 to 1 Aug 2025.
- 03 Feb 2020 According to a Janssen media release, data from this trial will be presented at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place February 13-15 in San Francisco.